OpenAlex
PricingAboutJobs
Log inGet started
Work

AML-961: CDK4/6 Inhibitor Use and Risk of Therapy-Related Myeloid Neoplasms Following Chemotherapy for HR+/HER2–Breast Cancer: A Landmark Competing Risks Analysis

HTML

Year: 2026
Type: conference-abstract
Source: Clinical Lymphoma Myeloma & Leukemia
DOI: 10.1016/s2152-2650(26)01877-x
Authors: Jacqueline T Nguyen, Arthur S Hong, Suraj R Rama, Oscar F Borja Montes, Danh Q Nguyen
Institutions: University of Florida Health, University of Florida, The University of Texas Southwestern Medical Center
Language: English

Topic: Advanced Breast Cancer Therapies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: CDK4/6 inhibitors, therapy-related myeloid neoplasms, hormone receptor-positive HER2-negative breast cancer, chemotherapy, myelodysplastic syndrome, acute myeloid leukemia, leukemogenesis, hematopoietic stem cell quiescence, competing risks, landmark analysis, immortal time bias, anthracycline chemotherapy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W7204689535
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security